The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; MSD
A phase 3 randomized, double-blind, placebo-controlled, multicenter, global study of durvalumab with and after chemoradiotherapy in patients with locally advanced, unresectable esophageal squamous cell carcinoma: KUNLUN.
 
Luhua Wang
No Relationships to Disclose
 
Ming Chen
No Relationships to Disclose
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Lucjan Wyrwicz
No Relationships to Disclose
 
Elizabeth Catherine Smyth
Employment - HCA International (I)
Honoraria - Bristol-Meyer Squibb; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Amal Therapeutics; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck Serono; Novartis; Roche; SERVIER; Zymeworks
Research Funding - Bristol-Meyers Squibb (Inst)
 
Anastasia Jiang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Di Zhang
Employment - AstraZeneca
 
Scott H. Robbins
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Philip He
Employment - AstraZeneca; Sanofi (I)
Stock and Other Ownership Interests - AstraZeneca; Celldex; Sanofi (I)
 
Alejandra Negro
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Nabil F. Saba
Honoraria - BioNTech; CUE Biopharma; Merck
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Blueprint Medicines; GlaxoSmithKline; Merck; Pfizer